Factsheet
January 29, 2019

Bioanalytical Immunoassay Services to Accelerate Biosimilar Development

Providing the tools and experience to support biosimilar studies
Biosimilars play an increasingly important role in the expanding global market for biotech medicines; and, navigating the challenges of developing a biosimilar through clinical trials while meeting regulatory guidelines requires an experienced partner. Q2 Solutions’ immunoassay services has experience developing, transferring and validating nonclinical and clinical assays to support biosimilar studies, including quantitative, immunogenicity and biomarkers assays.

Download our factsheet to learn more about our specific bioanalytic biosimilar capabilities.

Related Services:
Bioanalytical & ADME Laboratory Services

Accelerate and enhance your discovery, preclinical and clinical programs

Validated bioanalytical methods list

LC/MS/MS Methods, Immunoassay Biomarker Methods and LC/MS Biomarker Methods

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Assay Development for Large-Scale Clinical Studies

Bioanalytical expertise to support large-scale, international studies

Read More